Disclaimer: this software uses AI to aggregate and filter content. Please double-check sources before putting info to action.
π° News Media
- πΈ [National] Sober clubs - nytimes.com
- π [La Jolla, CA] Vaccine candidate from Scripps Research lab shows promise against addictiveness of Fentanyl - sandiegouniontribune.com
- π [National] 3 Takeaways from SAMHSAβs Annual Report for SUD Treatment Pros - bhbusiness.com
- π [National] How Ontarioβs Safer Supply Programs Impacted First Nations Peoples - filtermag.org
π£οΈ Social Pulse
Lived/Living Experience
Innovation
- π Victoria starts trial (ends 2027) of 20 free naloxone dispensing machines. Naloxone often (temporarily) reverses opioid overdose, safe even if opioids not taken. First machines at 3 hospitals. Putting it where easy... - @alexwodak on Bluesky
- π§ͺ π§ͺ Slide into a safer experience with the Transparency Triple Check for confident at-home testing: Screen for adulterants like fent using test strips, identify your substance with multiple reagents, and verify your... - @BunkPolice on X
Opposition Views
π City Updates
- No recent City Updates found.
π Academic Research
- π Barriers to Population Data Use in Overdose Fatality Reviews: Observational and Interview Study of Dashboard Deployment - JMIR Human Factors - 2026-07-27 - doi.org
- π§ͺ Work, Sex, and Substances: Differences in Self-Reported Chemsex Behaviors Between MSM Sex Workers and Digital Content Creators - Sexuality Research and Social Policy - 2026-07-22 - doi.org
- πΏ Kratom Toxicity: Pharmacologic Mechanisms, Clinical Risks, and Management Considerations - Cureus - 2026-07-24 - doi.org
βοΈ Law & Policy
- No hits in Law and Policy today.
πΈ Funding
Current
- π Substance Abuse and Mental Health Services Adminis - Comprehensive Opioid Recovery Centers - Deadline: Jul 29, 2026
- π¬ National Institutes of Health - Establishing a Center for the Advancement of Substance Use Disorder (SUD) Pharmacotherapeutics through Training and Preclinical Support (U54 Clinical Trial Not Allowed) - Deadline: Sep 30, 2026
- π¬ National Institutes of Health - Limited Competition: Growing Great Ideas: Research Education Course in Entrepreneurship and Product Development for Researchers Studying Drug Use, Drug Misuse, and Drug Addiction (UE5 Clinical Trial Not Allowed) - Deadline: Oct 1, 2026
- π¬ National Institutes of Health - Development of Interventions to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional) - Deadline: Aug 21, 2028
- π¬ National Institutes of Health - Avant Garde/Avenir Awards for Investigators Conducting High Risk/High Reward Research on HIV and Substance Use (or Substance Use Disorders) (DP1 Clinical Trial Optional) - Deadline: Sep 25, 2028
- π¬ National Institutes of Health - HEAL Initiative: Translating Addiction Epidemiology, Prevention, Treatment, and Recovery Research into Practice (R61/R33 - Clinical Trial Optional) - Deadline: Feb 9, 2029
- π₯ Hearst Foundations - Health - Hearst Foundations (Health) β Year-Round, Rolling Application (Non-endowment focus) - Minimum grant size is $100,000. - Deadline: Year-round, rolling application; there are no deadlines.
- π₯ Hearst Foundations - Social Service - Hearst Foundations β Social Service (General rolling application) - Minimum grant size is $100,000. - Deadline: Year-round, rolling application; there are no deadlines.
- π€ Smart Family Fund - Angel Philanthropy (First-Time Grants) - First-time grants range from $25,000 to $100,000. - Deadline: Open pitch